Clinical Trial Update: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating nonmyeloablative allogeneic hematopoietic stem cell transplantation as a treatment for pancreatic cancer. The study includes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer Stage III, Pancreatic Cancer Stage IV | Phase 1 | Status: UNKNOWN